Delivery Order SPE2DR25D2206-SPE2DR26F9EH7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CellCept 250 mg capsules (100-count units) with a ceiling value of $1,382.42. The contract, executed on August 25, 2025, with an ultimate completion date of August 26, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $31,318.38 to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100-count units) under a firm fixed price contract. The award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,508.35 to AmerisourceBergen Drug Corp for 100 capsules of CellCept 250 mg, an immunosuppressant medication commonly used in transplant and autoimmune disease management. This firm fixed-price delivery order, awarded on October 27, 2025, with an ultimate completion date of October 28, 2025, represents a competitively awarded contract with no set-aside designation. The pharmaceutical will be delivered to Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,014.65 to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (500-count packages) on August 7, 2025, with a completion date of August 8, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle (SPE2DX) that extends through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of CellCept 500 mg on August 25, 2025, with a ceiling value of $2,407.68 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 26, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100-count units) with a ceiling value of $9,754.64. This firm fixed-price delivery order, issued on August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion and extending through December 2026. The award was competitively awarded with no set-aside...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on July 16, 2025, for CellCept 250 mg capsules (100-count units) with a ceiling value of $17,152.58. This firm fixed-price delivery order, which is due for completion by July 17, 2025, represents a non-set-aside competitive award under the broader pharmaceutical supply framework. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 mg CellCept tablets (500-count units) valued at $44,285.82 with a firm fixed price structure. The delivery order, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a competitive award with no set-aside designation. Performance will be executed at the contractor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CellCept 500 mg tablets (100 count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order has a ceiling value of $27,735.62 and carries no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of CellCept 500 mg tablets (100-count units) with a ceiling value of $5,074.60. This is a firm fixed-price delivery order under an indefinite delivery contract vehicle, with an ultimate completion date of November 10, 2025. The contract was competitively awarded without set-aside designation to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9EH7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CellCept 250 mg capsules (100-count units) with a ceiling value of $1,261.78. The contract, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, is structured as a firm fixed price delivery order with no set-aside designation. This award represents a competitive procurement for pharmaceutical supply supporting federal medical needs, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $1 billion prime contract vehicle valued through December 2026 that enables comprehensive pharmaceutical and medical supply distribution to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical procurements through the Defense Logistics Agency's Medical Supply Chain, serving customers including the Defense Health Agency and the U.S. Coast Guard. The delivery order for CellCept, an immunosuppressant medication, reflects the company's role as a critical vendor for specialized pharmaceutical products required by federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/3/25 |